Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
502
502 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- EnobosarmPhase 22 trials
Veru Inc. · Obesity & Overweight, Mobility Disability, HOMA-IR
- GV101Phase 22 trials
Graviton Bioscience Corporation · Friedreich's Ataxia, Weight Management
- GW906Phase 22 trials
Shenzhen Salubris Pharmaceuticals Co., Ltd. · Hypertension
- HM15275Phase 22 trials
Hanmi Pharmaceutical Company Limited · Obese, Obesity, Type 2 Diabetes Mellitus
- HRS-7249Phase 22 trials
Fujian Shengdi Pharmaceutical Co., Ltd. · Hyperlipidemia
- HS235Phase 22 trials
35Pharma Inc., a GSK company · Pulmonary Arterial Hypertension, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction
- icovamenibPhase 22 trials
Biomea Fusion Inc. · Type 2 Diabetes
- IMM01-STEMPhase 22 trials
Immunis, Inc. · Muscle Performance, Sarcopenic Obesity, Muscle Atrophy
- IsuzinaxibAPX-115Phase 22 trials
Aptabio Therapeutics, Inc. · Diabetic Kidney Disease (DKD), Contrast Induced Acute Kidney Injury
- KDS2010Phase 22 trials
NeuroBiogen Co., Ltd · Overweight, Obesity, Obese Patients
- KHK4951Phase 22 trials
Kyowa Kirin Co., Ltd. · Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD)
- LAM-001Phase 22 trials
IRulya Therapeutics Inc. · Sarcoidosis Associated Pulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases and Hypoxia
- LT3001 DrugPhase 22 trials
Shanghai Pharmaceuticals Holding Co., Ltd · Acute Ischemic Stroke
- LY3549492Phase 22 trials
Eli Lilly · Obesity, Overweight
- matched to VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- matching dosagePhase 22 trials
Hangzhou Sciwind Biosciences Co., Ltd. · Weight Management, Overweight , Obesity, Overweight and/or Obesity
- MWN109 4Phase 22 trials
Shanghai Minwei Biotechnology Co., Ltd · Type 2 Diabetes Mellitus (T2DM), Overweight , Obesity
- NS-863Phase 22 trials
NS Pharma, Inc. · Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD), Pulmonary Arterial Hypertension
- NT-0796Phase 22 trials
NodThera Ltd. (a Rezera company) · Obesity and Type 2 Diabetes, Obesity
- of QLS1410Phase 22 trials
Qilu Pharmaceutical Co., Ltd. · Hypertension (HTN), Uncontrolled Hypertension
- PER-001 Intravitreal ImplantPhase 22 trials
Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma
- PER-001 Intravitreal Implant - ShamPhase 22 trials
Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma
- R3R01Phase 22 trials
River 3 Renal Corp. · Diabetic Kidney Disease, Alport Syndrome, Focal Segmental Glomerulosclerosis
- RBD5044Phase 22 trials
Ribocure Pharmaceuticals AB · Dyslipidemias, Hypertriglyceridemia
- REGN7544baloncibartPhase 22 trials
Regeneron · Postural Orthostatic Tachycardia Syndrome (POTS), Sepsis-Induced Hypotension
- SGC001Phase 22 trials
Beijing Sungen Biomedical Technology Co., Ltd · Acute Anterior ST-Segment Elevation Myocardial Infarction, Acute Pancreatitis
- SRSD107Phase 22 trials
Sirius Therapeutics Co., Ltd. · Venous Thromboembolism, Coronary Artery Disease (CAD), Peripheral Arterial Disease
- STP938Phase 22 trials
Step Pharma, SAS · Lymphoma, B-Cell, Lymphoma, T-Cell, Essential Thrombocythaemia
- SYH2069group 1, group 2Phase 22 trials
CSPC Ouyi Pharmaceutical Co., Ltd. · T2DM (Type 2 Diabetes Mellitus), Overweight or Obesity
- SYH2072Phase 22 trials
InnovStone Therapeutics Limited · Uncontrolled Hypertension, Resistant Hypertension, Primary Aldosteronism
- TE-8105 MADPhase 22 trials
Immunwork, Inc. · Overweight and Obesity
- TifeglipronRO7795081, CT-996Phase 22 trials
Roche (Genentech) · Type 2 Diabetes Mellitus, Obesity or Overweight
- TonlamarsenPhase 22 trials
Kardigan, Inc. · Hypertension, Acute Severe Hypertension, Hypertensive Emergency
- TS23Phase 22 trials
Translational Sciences, Inc. · Ischemic Stroke, Pulmonary Embolism
- TTI-0102cysteamine-pantetheine disulfidePhase 22 trials
Thiogenesis Therapeutics, Inc. · Nephropathic Cystinosis, Cystinosis, MELAS Syndrome
- TX000045Phase 22 trials
Tectonic Therapeutic · Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction, Hypertension, Pulmonary
- VortosiranPhase 22 trials
Ribocure Pharmaceuticals AB · Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)
- VTX3232Phase 22 trials
Zomagen Biosciences Ltd. · Idiopathic Parkinson Disease, Obesity
- VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- YN001Phase 22 trials
Beijing Inno Medicine Co., Ltd. · Atherosclerosis, Coronary Artery Disease, Atherosclerotic Cardiovascular Disease
- ACCG-2671Phase 21 trial
Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics · Obesity
- AcmopatideCT-868, RO7795074Phase 21 trial
Carmot Therapeutics, Inc. · Overweight, Obese, Type 1 Diabetes Mellitus
- AGN-193408Phase 21 trial
AbbVie · Open-angle Glaucoma, Ocular Hypertension
- AGP100Phase 21 trial
Agiana Pharmaceuticals · Catecholaminergic Polymorphic Ventricular Tachycardia
- ALN-2232Phase 21 trial
Alnylam Pharmaceuticals · Obesity
- ALV-100Phase 21 trial
Alveus Therapeutics, Inc. · Overweight , Obesity, Adults
- ALXN2350Phase 21 trial
AstraZeneca · BAG3 Mutation Associated Dilated Cardiomyopathy
- amsulostatPXS-5505Phase 21 trial
Syntara · Myelofibrosis, Primary Myelofibrosis (PMF), Post- Essential Thrombocythemia Myelofibrosis
- AP31969Phase 21 trial
Acesion Pharma · Atrial Fibrillation (AF)
- APL-9796Phase 21 trial
Apollo Therapeutics Ltd · Pulmonary Arterial Hypertension
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.